SSgA SPDR MSCI ACWI ex-US

Most Recent

  • uploads///A MA
    Real Insights

    Using Asian Markets’ Low Correlation with US Markets

    The correlation between US and international markets varies depending on market cycles.

    By Matthews Asia
  • uploads///Graph
    Company & Industry Overviews

    Allergan Generics Has Strengthened Teva’s Research Pipeline

    The acquisition of Allergan’s (AGN) generic business has helped Teva’s R&D pipeline become the strongest generic drug pipeline in the world.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Teva Is Well Placed to Dominate the European Generics Market

    Teva is in the first three positions in 26 countries in the European Union. The Teva–Allergan Generics deal helped Teva expand.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Teva’s Generic Value Chain Differentiates It from Its Peers

    In addition to its robust strategy, Teva Pharmaceutical also boasts of an extensive presence across all levels of the value chain for its generics business.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Teva Pharmaceutical Expected to See Strong Revenue Growth in 2016

    In 2016, Teva Pharmaceutical (TEVA) expects to earn revenues of $22.0 billion–$22.5 billion. This includes contribution from sales of Allergan Generics products.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Teva Aims to Improve Its Position with Actavis Generics Acquisition

    Teva Pharmaceutical expects to benefit from improved productivity after the completion of the deal with Actavis Generics.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Bendeka: How Teva Plans to Safeguard Oncology Revenues

    In the first quarter of 2016, Teva Pharmaceutical Industries (TEVA) launched a new drug, Bendeka, in partnership with Eagle Pharmaceuticals.

    By Margaret Patrick
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.